Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncology.
Saved in:
| Title: | Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncology. |
|---|---|
| Authors: | Che J; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea., Kwon WS; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim J; Pharos iBio Co., Ltd, Seoul, Republic of Korea., Jadamba E; Mogam Institute for Biomedical Research, Seoul, Republic of Korea., Han HJ; Celemics, Seoul, Republic of Korea., Kim Y; Celemics, Seoul, Republic of Korea., Lee CK; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea., Park CH; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea., Moon YJ; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea., Mun HB; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea., Chung HC; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea., Rha SY; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea. rha7655@yuhs.ac.; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. rha7655@yuhs.ac.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea. rha7655@yuhs.ac. |
| Source: | Scientific reports [Sci Rep] 2026 Feb 10; Vol. 16 (1). Date of Electronic Publication: 2026 Feb 10. |
| Publication Type: | Journal Article; Validation Study |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41667751 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncology. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Che+J%22">Che J</searchLink>; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kwon+WS%22">Kwon WS</searchLink>; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; Pharos iBio Co., Ltd, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jadamba+E%22">Jadamba E</searchLink>; Mogam Institute for Biomedical Research, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Han+HJ%22">Han HJ</searchLink>; Celemics, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+Y%22">Kim Y</searchLink>; Celemics, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+CK%22">Lee CK</searchLink>; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+CH%22">Park CH</searchLink>; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Moon+YJ%22">Moon YJ</searchLink>; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Mun+HB%22">Mun HB</searchLink>; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Chung+HC%22">Chung HC</searchLink>; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Rha+SY%22">Rha SY</searchLink>; Song-dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea. rha7655@yuhs.ac.; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. rha7655@yuhs.ac.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea. rha7655@yuhs.ac. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2026 Feb 10; Vol. 16 (1). <i>Date of Electronic Publication: </i>2026 Feb 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Validation Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41667751 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-026-37991-0 Languages: – Code: eng Text: English Titles: – TitleFull: Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncology. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Che J – PersonEntity: Name: NameFull: Kwon WS – PersonEntity: Name: NameFull: Kim J – PersonEntity: Name: NameFull: Jadamba E – PersonEntity: Name: NameFull: Han HJ – PersonEntity: Name: NameFull: Kim Y – PersonEntity: Name: NameFull: Lee CK – PersonEntity: Name: NameFull: Park CH – PersonEntity: Name: NameFull: Moon YJ – PersonEntity: Name: NameFull: Mun HB – PersonEntity: Name: NameFull: Chung HC – PersonEntity: Name: NameFull: Rha SY IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 02 Text: 2026 Feb 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |